They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
Subscribe To Our Newsletter & Stay Updated
